HONG KONG, SHANGHAI & FLORHAM PARK, N.J. - HUTCHMED (China) Limited (Nasdaq/AIM:HCM; SEHK:13) announced today that it has applied to the London Stock Exchange for a block admission of 43,616,756 ordinary shares to trading on AIM, according to a press release statement.
The admission is expected to become effective on June 11, 2026. The shares will be issued from time to time pursuant to the exercise of share options under the company’s 2026 Share Option Scheme.
The 2026 Share Option Scheme was approved at the company’s annual general meeting held on May 12, 2026. Under the scheme, HUTCHMED was authorized to grant options for a maximum of 43,616,756 ordinary shares with a par value of $0.10 each.
When issued, the ordinary shares will be fully paid and will rank equally with existing ordinary shares in issue. The company’s total issued share capital remains unchanged at 872,335,120 ordinary shares following the admission, with each share carrying one voting right and no shares held in treasury.
HUTCHMED will make six-monthly announcements regarding the utilization of the block admission in accordance with AIM Rule 29 and monthly announcements concerning any changes to its total voting rights.
The balance of the existing block admission related to the company’s previous share option scheme adopted in 2015, totaling 45,768,368 ordinary shares, remains in effect.
HUTCHMED is a commercial-stage biopharmaceutical company focused on the discovery, development and commercialization of targeted therapies and immunotherapies for cancer and immunological diseases. The company has three medicines marketed in China, with one also approved in the United States, Europe and Japan.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.
Most traders can read a chart. The hard part is the moment: entry window open, pattern forming, and you're still waiting for more confirmation. That's the conviction gap — and our chart analysis closes it. Unlike other AIs that just read data, our Vision AI literally "sees" your charts and hands you a complete trading plan: entry, stop-loss, and profit target in under 60 seconds. Know exactly what to do next, every time.